Categories: AIDS, HIV, global health, antiretroviral drugs
|Topic:||Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities|
THE NATIONAL ACADEMIES
Institute of Medicine
Board on Global Health
Committee on Examining the Probable Consequences of Alternative Patterns
of Widespread Antiretroviral Drug Use in Resource-Constrained Settings
Tuesday, July 6, 2004 -- 1:30 p.m.
419 Dirksen Senate Office Bldg.
Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities
James W. Curran, Dean, Rollins School of Public Health, Emory University, Atlanta, Georgia and Co-Chair, Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings, Board on Global Health, Institute of Medicine, The National Academies
With billions of dollars now available to provide HIV/AIDS drugs to developing nations, the questions of when and how to "scale up" treatment for millions of needy individuals must be addressed. Significant challenges remain, including a shortage of health care workers and the possibility that a less-than-optimal introduction of therapy could foster more rapid development of drug resistance. This new report, from the Institute of Medicine, offers a framework and key principles to guide program managers on how best to initiate and run treatment programs.
This briefing was for members of Congress and congressional staff only. The report was publicly released on July 7, 2004 and can be found, in its entirety, on the Web site of the National Academies Press.